Most Recent Articles by James G. DIckinson
With POC on the march, the FDA will have to stretch its monitoring efforts to keep up
Public Citizen tells FDA it should withdraw draft guidance that it believes will allow drugmakers to tell physicians marketed drugs are less risky than their labels indicate.
The former FDA director of medical device compliance has petitioned the agency to make oral contraceptives over-the-counter.
Hospira is taking to the courts to fight off generic threats to its hospital sedation drug Precedex
Two FDA guidance documents on how health product manufacturers may participate in social media have each drawn criticism from affected industry and consumer groups.
More Articles by James G. DIckinson
This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.